The 20 Best Familial Prostate Cancer Doctors Near Me in Bronx, NY

William Bodner is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Bodner is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Familial Prostate Cancer.

Michael Morris is an Oncologist practicing medicine in New York, New York. Dr. Morris is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Vocal Cord Dysfunction, Hip Replacement, and Knee Replacement. Dr. Morris is currently accepting new patients.

Dana Rathkopf is an Oncologist practicing medicine in New York, New York. Dr. Rathkopf is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy. Dr. Rathkopf is currently accepting new patients.

Behfar Ehdaie is a Urologist practicing medicine in New York, New York. Dr. Ehdaie is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Ehdaie is currently accepting new patients.

Howard Scher is an Oncologist practicing medicine in New York, New York. Dr. Scher is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Orchiectomy, and Prostatectomy. Dr. Scher is currently accepting new patients.

Ashutosh Tewari is a Urologist practicing medicine in New York, New York. Dr. Tewari is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Vasectomy. Dr. Tewari is currently accepting new patients.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Byung-han Rhieu is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Rhieu is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Radiation Induced Meningioma, Meningioma, and Primitive Neuroectodermal Tumor (PNET).

Franklin C. Lowe, MD, Professor of Urology and Vice-Chair of the Department, is also Director of Urologic Services, Jack D. Weiler Hospital. An expert in the treatment of benign and malignant disorders of the prostate, Dr. Lowe has published over 150 articles on multiple urological topics and has lectured extensively throughout the world. Prior to joining The Department of Urology at Montefiore, Dr. Lowe held faculty and leadership positions at Columbia University, Mount Sinai School of Medicine and at St. Luke’s/ Roosevelt Hospital in Manhattan. A Graduate of Princeton University, Dr. Lowe obtained both his Medical and Masters of Public Health degrees from Columbia University College of Physicians and Surgeons. He completed his internship and residency in Surgery and Urology at The James Buchanan Brady Urological Institute of Johns Hopkins University. Dr. Lowe previously served as the Chairman of The American Urological Association’s Alternative Medicine Committee and as a member of the BPH Guidelines Committee. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Prostatectomy, and Ureteroscopy.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Israel Deutsch, M.D., is Assistant Professor of Radiation Oncology at New York-Presbyterian/Columbia University Medical Center. Dr. Deutsch cares for patients with all types of cancer, with a special interest in Prostate, Gynecologic, and Head & Neck cancers. He is Director of Brachytherapy Services in the Department of Radiation Oncology. Dr. Deutsch is a respected researcher with numerous peer-reviewed contributions to medical literature and has edited many book chapters in his areas of expertise. He is a member of the Review Committee on Continuing Medical Education at Columbia University Medical Center. Dr. Deutsch received his medical degree from Albert Einstein College of Medicine. He then received transitional year training during an internship at New York Hospital Queens, after which he completed his radiation oncology residency at SUNY Downstate Medical Center. Dr. Deutsch then furthered his training with a fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center. In collaboration with several clinical and basic science colleagues, he is conducting a number of clinical and translational studies. Dr. Deutsch sits on the Internal Review Board (IRB) for Clinical Trials and is also a member of the Children’s Oncology Group (COG) as Investigator representing the Department of Radiation Oncology. Dr. Deutsch is very involved in residency education and serves as Associate Director of the Radiation Oncology Residency Program at New York Presbyterian/Columbia University Medical Center. Dr. Deutsch is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Melanoma of the Eye, and Endometrial Cancer. Dr. Deutsch is board certified in Radiation Oncology. Dr. Deutsch is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Dr. Stein is an Associate Professor of Medical Oncology at Columbia University Medical Center. He is a recognized expert in field of genitourinary oncology – treating patients with prostate, kidney, bladder and testicular cancers. He is also a member of the Experimental Therapeutics program, investigating novel therapies across all solid tumors. In addition to providing standard therapies for the treatment of genitourinary cancers such as hormonal therapy, molecularly targeted therapy and chemotherapy, Dr. Stein leads multiple investigator initiated and industry sponsored clinical trials. Dr. Stein has a particular interest in the development of novel immune therapies for the treatment of prostate cancer, both in men with early recurrence of prostate cancer as well as in men with more advanced prostate cancer. He is also helping to lead two national trials in kidney cancer sponsored by the National Cancer Institute.Dr. Stein received his B.S. in Molecular Biophysics and Biochemistry from Yale University. He earned his medical degree at New York Medical College, receiving the graduation award in oncology for his published research. He completed a residency in internal medicine at Montefiore Medical Center, and a fellowship in Hematology and Medical Oncology at Mount Sinai Medical Center. Prior to joining Columbia University, Dr. Stein practiced genitourinary oncology for 13 years at Rutgers University and has been an author on over 60 publications including guidelines for assessing the efficacy of new drugs in prostate cancer and recommendations for the use of immunotherapy to treat prostate cancer. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Familial Prostate Cancer. Dr. Stein is board certified in Medical Oncology. Dr. Stein is currently accepting new patients.

Marc Janis is a Urologist practicing medicine in Mount Vernon, New York. Dr. Janis is rated as an Advanced provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

An internationally renowned expert in prostate cancer treatment and radiation oncology pioneer, Louis Potters, MD, FASTRO, FABS, FACR serves as Senior Vice President and Deputy Physician-in-Chief of the Northwell Cancer Institute while chairing its Department of Radiation Medicine. His contributions span clinical excellence, research innovation, and healthcare policy development. As a key architect of national cancer treatment guidelines and advisor to the US Nuclear Regulatory Commission, Dr. Potters has helped shape modern radiation oncology standards and safety protocols.His distinguished service includes positions on the Commission on Cancer executive committee, National Quality Forum panels, and multiple Health and Human Services committees, where he has been instrumental in advancing healthcare quality nationwide. As senior editor of Practical Radiation Oncology and editorial board member for leading journals including Oncology and Brachytherapy, he continues to guide professional discourse and scientific advancement in the field. A member of the prestigious Alpha Omega Alpha honor society, Dr. Potters has demonstrated exceptional commitment to medical excellence throughout his career. He recognized year over year in a number of Best Doctor awards by Castle Connolly, is featured in New York Magazine and as a NY Times SuperDoc.Throughout his 32-year clinical practice treating thousands of prostate cancer patients, Dr. Potters has pioneered innovative approaches to patient care and quality assurance. His leadership of one of the nation's largest radiation oncology departments has fostered excellence in patient care, groundbreaking research, and comprehensive medical education. The Smarter Radiation Oncology program he developed has gained international recognition for setting new standards in quality metrics, safety protocols, and patient experience. His academic contributions include over 200 peer-reviewed publications that have significantly advanced the field of radiation oncology and prostate cancer treatment.Under his guidance, the Northwell Health Department of Radiation Medicine has become a leading force in implementing cutting-edge treatments while training the next generation of oncology leaders. Dr. Potters continues to drive innovation in personalized cancer care, process improvement, and clinical outcomes, maintaining Northwell's position at the forefront of modern oncology practice. Dr. Potters is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Potters is board certified in American Board Of Internal Medicine and American Board Of Radiology/Radiation Oncology.